| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Biogen Inc.'s insiders have reduced their positions by a net 1,186 shares worth roughly $240K.
BIIB sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 41.8K | $8.41M | - | |
| CEO | 29.9K | - | - | |
| Dir | 25.8K | - | - | |
| VP | 22.4K | $4.50M | - | |
| Other | 19.6K | $3.82M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2023 | Gregory Ginger | EVP, Human Resources | Sell10b5-1 | 2,681 | $300.00 | $804,300.00 | -24.0% | -13.6% | -31.3% | |
| Apr 4, 2023 | Singhal Priya69 | Head of Development | Sell10b5-1 | 91 | $277.11 | $25,217.01 | -3.1% | +3.7% | -25.0% | |
| Mar 28, 2023 | Singhal Priya69 | Head of Development | Sell | 568 | $270.06 | $153,394.08 | -16.7% | +4.2% | -19.9% | |
| Nov 14, 2022 | Gregory Ginger | EVP, Human Resources | Sell | 5,610 | $300.11 | $1,683,617.10 | -49.6% | -2.9% | -24.7% | |
| Oct 27, 2022 | Alexander Susan H | EVP Chief Legal Officer &Corp Sec | Sell | 5,532 | $280.70 | $1,552,832.40 | -12.3% | +5.2% | -15.6% | |
| Jun 7, 2021 | Sandrock Alfred69 | Head of Research &Development | Sell | 7,672 | $440.00 | $3,375,680.00 | -43.0% | -17.3% | -49.2% | |
| Jun 7, 2021 | Guindo Chirfi | Head of Glob Prod Strat &Com | Sell | 3,087 | $440.00 | $1,358,280.00 | -51.4% | -17.3% | -49.2% | |
| Jun 4, 2021 | Posner Brian S63 | Director | Sell | 360 | $274.17 | $98,701.20 | -4.6% | +17.3% | -29.9% | |
| Feb 9, 2021 | Mantas Jesus B | Director | Buy | 898 | $267.00 | $239,766.00 | +43.9% | - | - | |
| Nov 30, 2020 | Vounatsos Michel | Chief Executive Officer | Buy | 3,100 | $241.31 | $748,046.74 | +9.8% | - | - |